USFDA APPLICATION NUMBER - 204168 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 40MG BASE
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
LEVOMILNACIPRAN HYDROCHLORIDE(UNII: 371U2ZK31U) (levomilnacipran - UNII:UGM0326TXX) | levomilnacipran | 40mg |
Inactive Ingredients
Ingredient Name | Avera McKennan Hospital |
---|---|
ethylcelluloses(7Z8S9VYZ4B) | |
FERRIC OXIDE YELLOW(EX438O2MRT) | |
FERROSOFERRIC OXIDE(XM0M87F357) | |
hypromelloses(3NXW29V3WO) | |
povidone(FZ989GH94E) | |
shellac(46N107B71O) | |
SUCROSE(C151H8M554) | |
talc(7SEV7J4R1U) | |
titanium dioxide(15FIX9V2JP) | |
triethyl citrate(8Z96QXD6UM) |
LOOKING FOR A SUPPLIER?